Obstetrics and Gynecology Residents Can Accurately Classify Benign Ovarian Tumors Using the International Ovarian Tumor Analysis Rules
- PMID: 32012337
- DOI: 10.1002/jum.15234
Obstetrics and Gynecology Residents Can Accurately Classify Benign Ovarian Tumors Using the International Ovarian Tumor Analysis Rules
Abstract
Objectives: Recognition of benign versus malignant tumors is essential in gynecologic ultrasound (US). The International Ovarian Tumor Analysis (IOTA) rules have been proposed as part of resident US training. The objective of this study was to examine whether they could be accurately used by obstetrics and gynecology residents in Rwanda.
Methods: Patients undergoing explorative laparotomy for adnexal masses at the University Teaching Hospital of Kigali were included. Before the study, a didactic lecture on the IOTA rules for classifying adnexal masses was performed. Preoperative transabdominal US examinations were performed by residents at different levels of training, who were blinded to the results of prior US examinations. The IOTA classification was compared to the final pathologic diagnosis.
Results: There were 72 patients who underwent 116 US examinations. Only 15.5% of US examinations were considered inconclusive. First-year residents (12) correctly diagnosed 18 of 20 masses (90%) as benign and 4 of 4 as malignant. Second-year residents (9) classified 29 of 29 masses correctly. Third-year residents (10) accurately identified 21 of 22 (95.5%) as benign and 5 of 5 as malignant. Fourth-year residents (13) accurately identified 11 of 12 (91.7%) as benign and 6 of 6 as malignant. Therefore, 74 of 78 tumors (94.9%) considered benign by IOTA rules were confirmed by histologic results. Similarly, all 20 tumors classified as malignant were confirmed. Overall, the sensitivities to diagnose benign and malignant tumors by the IOTA rules were 83.3% and 100%, respectively. The positive and negative predictive values were 100% and 94.9%. There were no significant differences noted between residency years.
Conclusions: All levels of Rwandan obstetrics and gynecology residents were able to use the IOTA rules to accurately distinguish benign from malignant tumors.
Keywords: International Ovarian Tumor Analysis; global health; low-resource country; residency ultrasound training.
© 2020 by the American Institute of Ultrasound in Medicine.
Similar articles
-
External validation of IOTA simple descriptors and simple rules for classifying adnexal masses.Ultrasound Obstet Gynecol. 2016 Sep;48(3):397-402. doi: 10.1002/uog.15854. Ultrasound Obstet Gynecol. 2016. PMID: 26748432
-
Vessel morphology depicted by three-dimensional power Doppler ultrasound as second-stage test in adnexal tumors that are difficult to classify: prospective diagnostic accuracy study.Ultrasound Obstet Gynecol. 2021 Feb;57(2):324-334. doi: 10.1002/uog.22191. Ultrasound Obstet Gynecol. 2021. PMID: 32853459 Free PMC article.
-
Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.Ultrasound Obstet Gynecol. 2019 May;53(5):693-700. doi: 10.1002/uog.20163. Ultrasound Obstet Gynecol. 2019. PMID: 30353585
-
The diagnostic performance of International Ovarian Tumor Analysis: Simple Rules for diagnosing ovarian tumors-a systematic review and meta-analysis.Front Oncol. 2025 Jan 20;14:1474930. doi: 10.3389/fonc.2024.1474930. eCollection 2024. Front Oncol. 2025. PMID: 39902128 Free PMC article. Review.
-
Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis.Ultrasound Obstet Gynecol. 2014 Nov;44(5):503-14. doi: 10.1002/uog.13437. Epub 2014 Oct 13. Ultrasound Obstet Gynecol. 2014. PMID: 24920435 Review.
Cited by
-
Hydrogen Sulfide Expression May Affect Ovarian Cancer Progression and Drug Resistance.Int J Womens Health. 2025 May 28;17:1533-1545. doi: 10.2147/IJWH.S515836. eCollection 2025. Int J Womens Health. 2025. PMID: 40453043 Free PMC article.
-
Ultrasound Assessment of Adnexal Pathology: Standardized Methods and Different Levels of Experience.Medicina (Kaunas). 2021 Jul 13;57(7):708. doi: 10.3390/medicina57070708. Medicina (Kaunas). 2021. PMID: 34356989 Free PMC article.
References
-
- American College of Obstetrics and Gynecology. Practice Bulletin No 176: evaluation and management of adnexal masses. Obstet Gynecol 2016; 128:210-226.
-
- Timmerman D, Testa AC, Bourne T, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005; 23:8794-8801.
-
- Timmerman D, Ameye L, Fischerova D, et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 2010; 341:c6839.
-
- Timmerman D, Van Calster B, Testa A, et al. Predicting the risk of malignancy in adnexal masses based on the simple rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 2016; 214:424-437.
-
- Garg S, Kaur A, Mohl JK, Sibia PK, Kaur N. Evaluation of IOTA simple ultrasound rules to distinguish benign and malignant ovarian tumours. J Clin Diagn Res 2017; 11:TC06-TC09.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical